Search - tctmd.com

Displaying 1 - 20 of 69

Sort: Relevancy | Date

What’s Going to Be Hot at TCT 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

June 27, 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

News Conference News EuroPCR 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

May 21, 2025

Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli

News Daily News

Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli

May 19, 2025

Solid Durability Seen With Surgical Resilia Tissue Aortic Valve

News Conference News HVS 2025

Solid Durability Seen With Surgical Resilia Tissue Aortic Valve

Yael L. Maxwell

April 21, 2025

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

News Daily News

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

April 11, 2025

EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes

News Conference News ACC 2025

EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes

April 07, 2025

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

News Conference News CRT 2025

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

March 10, 2025

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

News Conference News PCR London Valves 2024

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Michael O'Riordan

November 27, 2024

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

News Conference News PCR London Valves 2024

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Michael O'Riordan

November 26, 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

November 01, 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

October 30, 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

October 28, 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

October 28, 2024

TCT 887: SAPIEN 3 Ultra Resilia: Bench Insights to Hydrodynamic Function for TAVR, Valve-in-Valve and Redo-TAVR

Presentation TCT 2024

TCT 887: SAPIEN 3 Ultra Resilia: Bench Insights to Hydrodynamic Function for TAVR, Valve-in-Valve and Redo-TAVR

Presenter: Julien Delarive

October 28, 2024

TCT 160: Edwards Sapien 3 Ultra Resilia Valves Demonstrate Lower Gradients at 1 Year Compared to Sapien 3 Ultra Valves

Presentation TCT 2024

TCT 160: Edwards Sapien 3 Ultra Resilia Valves Demonstrate Lower Gradients at 1 Year Compared to Sapien 3 Ultra Valves

Presenter: Joseph Aragon

October 28, 2024

TCT 164: Immediate and Pre-Discharge Post-TAVR Invasive and Echocardiographic Hemodynamics of Sapien 3 Resilia, Sapien 3 Ultra and Self-Expanding Valves

Presentation TCT 2024

TCT 164: Immediate and Pre-Discharge Post-TAVR Invasive and Echocardiographic Hemodynamics of Sapien 3 Resilia, Sapien 3 Ultra and Self-Expanding Valves

Presenter: Shazil Mahmood

October 28, 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

TCT 86: Real-World 30-Day Outcomes for the SAPIEN 3 Ultra Resilia Transcatheter Heart Valve in the Treatment of Failed Bioprosthetic Mitral Valves: A Propensity-Matched Analysis

Presentation TCT 2024

TCT 86: Real-World 30-Day Outcomes for the SAPIEN 3 Ultra Resilia Transcatheter Heart Valve in the Treatment of Failed Bioprosthetic Mitral Valves: A Propensity-Matched Analysis

Presenter: Tiberio Frisoli

October 27, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.